Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancer

NCT01802567 is registered in ClinicalTrials.gov with Giselle Sholler as lead sponsor.

NCT NCT01802567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01802567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Trial Using Molecular-Guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancer
Lead sponsor
Giselle Sholler
Phase
Not applicable
Overall status
Completed
Start date
March 4, 2013
Completion date
January 17, 2024
Enrollment
52 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumors, medulloblastoma, neuroblastoma, rare tumors